Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-04-18

Clinical Trial Update: A Study to Evaluate the Effect of Dupilumab on Exercise Capacity in Adult Patients With Asthma [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluated dupilumab effects on exercise capacity in adults with asthma; results have been posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dupilumab (dupilumab)

Snippet

Sponsor: Regeneron Pharmaceuticals | Conditions: Asthma | Phase 4 | Status: COMPLETED | Results posted: 2024-04-18